Drug intelligence / Profile preview

shBRD4

Development stage
Preclinical
Lead developer
NYU Grossman School of Medicine
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

shBRD4 is a short hairpin RNA (shRNA) designed to silence the expression of Bromodomain-containing protein 4 (BRD4), a member of the BET (bromodomain and extra-terminal motif) family. BRD4 acts as an epigenetic reader that binds to acetylated lysine residues on histones, playing a critical role in regulating the transcription of genes involved in cell cycle progression and proliferation. In preclinical studies, particularly in melanoma, shBRD4 has been used to demonstrate that BRD4 knockdown suppresses tumor cell growth, colony formation, and in vivo tumor progression. This research tool helped validate BRD4 as a therapeutic target, leading to the development of small-molecule BET inhibitors.

Other names
BRD4 shRNABRD-4 shRNABRD 4 shRNAshort hairpin RNA targeting BRD4
02

Targets

BRD4 (Bromodomain-containing protein 4)

Beyond the preview

Go deeper on shBRD4.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on shBRD4.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call